Fenju Wei

436 total citations
13 papers, 365 citations indexed

About

Fenju Wei is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Fenju Wei has authored 13 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Virology and 6 papers in Molecular Biology. Recurrent topics in Fenju Wei's work include HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (9 papers) and Chemical Synthesis and Analysis (4 papers). Fenju Wei is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (9 papers) and Chemical Synthesis and Analysis (4 papers). Fenju Wei collaborates with scholars based in China, Belgium and Spain. Fenju Wei's co-authors include Xinyong Liu, Peng Zhan, Dongwei Kang, Da Feng, Erik De Clercq, Christophe Pannecouque, Yanying Sun, Tong Zhao, Zhao Wang and Zengjun Fang and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Acta Pharmaceutica Sinica B.

In The Last Decade

Fenju Wei

13 papers receiving 361 citations

Peers

Fenju Wei
Yanying Sun China
Abigail Baldridge United States
Da Feng China
Hisateru Aramaki Japan
Takahisa Motomura Japan
Mark W. Embrey United States
Geert Pille United States
Massimiliano La Colla Italy
G Riess Belgium
Yanying Sun China
Fenju Wei
Citations per year, relative to Fenju Wei Fenju Wei (= 1×) peers Yanying Sun

Countries citing papers authored by Fenju Wei

Since Specialization
Citations

This map shows the geographic impact of Fenju Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenju Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenju Wei more than expected).

Fields of papers citing papers by Fenju Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenju Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenju Wei. The network helps show where Fenju Wei may publish in the future.

Co-authorship network of co-authors of Fenju Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Fenju Wei. A scholar is included among the top collaborators of Fenju Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenju Wei. Fenju Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhang, Lina, Fenju Wei, Jiwei Zhang, et al.. (2022). Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors. European Journal of Medicinal Chemistry. 243. 114760–114760. 11 indexed citations
2.
Zhang, Lina, Fenju Wei, David Borrego, et al.. (2022). Design, synthesis, and biological evaluation of novel double-winged galloyl derivatives as HIV-1 RNase H inhibitors. European Journal of Medicinal Chemistry. 240. 114563–114563. 5 indexed citations
3.
Kang, Dongwei, Fenju Wei, Lin Sun, et al.. (2021). Discovery, optimization, and target identification of novel coumarin derivatives as HIV-1 reverse transcriptase-associated ribonuclease H inhibitors. European Journal of Medicinal Chemistry. 225. 113769–113769. 12 indexed citations
4.
Feng, Da, Fenju Wei, Yanying Sun, et al.. (2021). Boronic acid-containing diarylpyrimidine derivatives as novel HIV-1 NNRTIs: Design, synthesis and biological evaluation. Chinese Chemical Letters. 32(12). 4053–4057. 20 indexed citations
5.
Kang, Dongwei, Da Feng, Yanying Sun, et al.. (2020). Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties. Journal of Medicinal Chemistry. 63(9). 4837–4848. 59 indexed citations
6.
Kang, Dongwei, Yanying Sun, N. Arul Murugan, et al.. (2020). Structure–Activity Relationship Exploration of NNIBP Tolerant Region I Leads to Potent HIV-1 NNRTIs. ACS Infectious Diseases. 6(8). 2225–2234. 13 indexed citations
7.
Kang, Dongwei, Francesc X. Ruiz, Da Feng, et al.. (2020). Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel. Journal of Medicinal Chemistry. 63(3). 1298–1312. 37 indexed citations
8.
Kang, Dongwei, Da Feng, Lanlan Jing, et al.. (2020). In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP. European Journal of Medicinal Chemistry. 193. 112237–112237. 27 indexed citations
9.
Wei, Fenju, Dongwei Kang, Srinivasulu Cherukupalli, et al.. (2020). Discovery and optimizing polycyclic pyridone compounds as anti-HBV agents. Expert Opinion on Therapeutic Patents. 30(9). 715–721. 10 indexed citations
10.
Kang, Dongwei, Tong Zhao, Zhao Wang, et al.. (2019). Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors. Communications Chemistry. 2(1). 29 indexed citations
11.
12.
Kang, Dongwei, Da Feng, Tiziana Ginex, et al.. (2019). Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs. Acta Pharmaceutica Sinica B. 10(5). 878–894. 44 indexed citations
13.
Feng, Da, Fenju Wei, Zhao Wang, et al.. (2018). Development of a practical synthesis of etravirine via a microwave-promoted amination. Chemistry Central Journal. 12(1). 144–144. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanying Sun Breakdown of academic impact, for papers by Abigail Baldridge Breakdown of academic impact, for papers by Da Feng Breakdown of academic impact, for papers by Hisateru Aramaki Breakdown of academic impact, for papers by Takahisa Motomura Breakdown of academic impact, for papers by Mark W. Embrey Breakdown of academic impact, for papers by Geert Pille Breakdown of academic impact, for papers by Massimiliano La Colla Breakdown of academic impact, for papers by G Riess
Rankless by CCL
2026